betaine has been researched along with Cardiac Failure in 7 studies
glycine betaine : The amino acid betaine derived from glycine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Few studies have examined the associations of trimethylamine-N-oxide (TMAO) and its precursors (choline, betaine, dimethylglycine, and L-carnitine) with the risk of atrial fibrillation (AF) and heart failure (HF)." | 8.02 | Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study. ( Alonso-Gómez, A; Bulló, M; Clish, C; Corella, D; Estruch, R; Fiol, M; Fitó, M; Guasch-Ferré, M; Hernández-Alonso, P; Hu, FB; Li, J; Liang, L; Martínez-González, MA; Papandreou, C; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Santos-Lozano, JM; Serra-Majem, L; Toledo, E, 2021) |
| "The highest and lowest quintiles of urinary betaine excretion associated with risk of heart failure (p = 0." | 7.78 | Betaine and secondary events in an acute coronary syndrome cohort. ( Atkinson, W; Chambers, ST; Elmslie, JL; Frampton, CM; George, PM; Lever, M; Molyneux, SL; Richards, AM; Slow, S; Troughton, RW, 2012) |
| "Few studies have examined the associations of trimethylamine-N-oxide (TMAO) and its precursors (choline, betaine, dimethylglycine, and L-carnitine) with the risk of atrial fibrillation (AF) and heart failure (HF)." | 4.02 | Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study. ( Alonso-Gómez, A; Bulló, M; Clish, C; Corella, D; Estruch, R; Fiol, M; Fitó, M; Guasch-Ferré, M; Hernández-Alonso, P; Hu, FB; Li, J; Liang, L; Martínez-González, MA; Papandreou, C; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Santos-Lozano, JM; Serra-Majem, L; Toledo, E, 2021) |
| "Trimethylamine N-oxide (TMAO), a gut-related metabolite, is associated with heart failure (HF) outcomes." | 4.02 | Association of gut-related metabolites with outcome in acute heart failure. ( Bernieh, D; Cassambai, S; Heaney, LM; Israr, MZ; Jones, DJL; Ng, LL; Salzano, A; Suzuki, T; Yazaki, Y, 2021) |
| "The highest and lowest quintiles of urinary betaine excretion associated with risk of heart failure (p = 0." | 3.78 | Betaine and secondary events in an acute coronary syndrome cohort. ( Atkinson, W; Chambers, ST; Elmslie, JL; Frampton, CM; George, PM; Lever, M; Molyneux, SL; Richards, AM; Slow, S; Troughton, RW, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Wargny, M | 1 |
| Croyal, M | 1 |
| Ragot, S | 1 |
| Gand, E | 1 |
| Jacobi, D | 1 |
| Trochu, JN | 1 |
| Prieur, X | 1 |
| Le May, C | 1 |
| Goronflot, T | 1 |
| Cariou, B | 1 |
| Saulnier, PJ | 1 |
| Hadjadj, S | 1 |
| Papandreou, C | 1 |
| Bulló, M | 1 |
| Hernández-Alonso, P | 1 |
| Ruiz-Canela, M | 1 |
| Li, J | 1 |
| Guasch-Ferré, M | 1 |
| Toledo, E | 1 |
| Clish, C | 1 |
| Corella, D | 1 |
| Estruch, R | 1 |
| Ros, E | 1 |
| Fitó, M | 1 |
| Alonso-Gómez, A | 1 |
| Fiol, M | 1 |
| Santos-Lozano, JM | 1 |
| Serra-Majem, L | 1 |
| Liang, L | 1 |
| Martínez-González, MA | 1 |
| Hu, FB | 1 |
| Salas-Salvadó, J | 1 |
| Israr, MZ | 1 |
| Bernieh, D | 1 |
| Salzano, A | 1 |
| Cassambai, S | 1 |
| Yazaki, Y | 1 |
| Heaney, LM | 1 |
| Jones, DJL | 1 |
| Ng, LL | 1 |
| Suzuki, T | 1 |
| Lv, Y | 1 |
| Ma, P | 2 |
| Wang, J | 1 |
| Xu, Q | 1 |
| Fan, J | 1 |
| Yan, L | 1 |
| Zhou, R | 1 |
| Trøseid, M | 1 |
| Ueland, T | 1 |
| Hov, JR | 1 |
| Svardal, A | 1 |
| Gregersen, I | 1 |
| Dahl, CP | 1 |
| Aakhus, S | 1 |
| Gude, E | 1 |
| Bjørndal, B | 1 |
| Halvorsen, B | 1 |
| Karlsen, TH | 1 |
| Aukrust, P | 1 |
| Gullestad, L | 1 |
| Berge, RK | 1 |
| Yndestad, A | 1 |
| Lever, M | 1 |
| George, PM | 1 |
| Elmslie, JL | 1 |
| Atkinson, W | 1 |
| Slow, S | 1 |
| Molyneux, SL | 1 |
| Troughton, RW | 1 |
| Richards, AM | 1 |
| Frampton, CM | 1 |
| Chambers, ST | 1 |
| BORSOOK, ME | 1 |
| BORSOOK, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| GutHeart: Targeting Gut Microbiota to Treat Heart Failure[NCT02637167] | Phase 2 | 150 participants (Anticipated) | Interventional | 2016-03-11 | Recruiting | ||
| The Effects of Medium-term Oral Guanidinoacetic Acid (GAA) Administration on Human Performance, Body Composition, and Metabolic Outcomes in Physically Active Men and Women[NCT01133899] | Phase 1/Phase 2 | 40 participants (Actual) | Interventional | 2010-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 other studies available for betaine and Cardiac Failure
| Article | Year |
|---|---|
Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohort.
Topics: Aged; Betaine; Biomarkers; Carnitine; Choline; Cohort Studies; Cysteine; Diabetes Mellitus, Type 2; | 2022 |
Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study.
Topics: Aged; Atrial Fibrillation; Betaine; Carnitine; Case-Control Studies; Choline; Female; Heart Failure; | 2021 |
Association of gut-related metabolites with outcome in acute heart failure.
Topics: Acetylcarnitine; Acute Disease; Aged; Aged, 80 and over; Betaine; Carnitine; Choline; Female; Gastro | 2021 |
Betaine alleviates right ventricular failure via regulation of Rho A/ROCK signaling pathway in rats with pulmonary arterial hypertension.
Topics: Actins; Administration, Oral; Animals; Apoptosis; Arterioles; Betaine; Cardiotonic Agents; Disease M | 2021 |
Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Topics: Aged; Betaine; Biomarkers; Choline; Chronic Disease; Female; Heart Failure; Humans; Intestinal Mucos | 2015 |
Betaine and secondary events in an acute coronary syndrome cohort.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Betaine; Chromatography, High Pressure Liquid; Coh | 2012 |
Treatment of cardiac decompensation with betaine and glycocyamine.
Topics: Betaine; Biochemical Phenomena; Cardiovascular Diseases; Creatine; Glycine; Heart Failure; Humans | 1951 |